IL20RA and urinary bladder carcinoma: Besides, IL20RA expression is also positively correlated with the clinical outcome of patients in patients of bladder carcinoma, uterine corpus endometrial carcinoma, rectum adenocarcinoma, and gastric cancer (Figure 2—figure supplement 1).